Related Experiment Video
Updated: Aug 17, 2026
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Preliminary experience with robot-assisted laparoscopic staging of gynecologic malignancies
R Kevin Reynolds1, William M Burke, Arnold P Advincula
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Michigan Medical Center, L 4000 Women's Hospital, 1500 East Medical Center Dr, Ann Arbor, MI 48109-0276, USA. rkr@umich.edu
Objective:
To evaluate the feasibility of integrating robot-assisted technology in the performance of laparoscopic staging of gynecologic malignancies.
Methods:
Seven patients underwent robot-assisted laparoscopic staging procedures for gynecologic cancers. Data were collected and analyzed as a retrospective case series analysis.
Results:
We attempted 7 robot-assisted laparoscopic staging procedures with no conversions to laparotomy. The median lymph node count for lymphadenectomy was 15 (range, 4 to 29). Mean operating time was 257 minutes (range, 174 to 345). The average estimated blood loss was 50 mL. One patient developed sinusitis and required intravenous antibiotics. The median hospital stay was 2 days.
Conclusion:
Robot-assisted laparoscopic staging is a feasible technique that may overcome the surgical limitations of conventional laparoscopy.
